Case Western Reserve University & University Hospitals Cleveland Medical Center is evaluating the potential benefits of an investigational medicine for people with mild-to-moderate Alzheimer’s Disease. Dr. Alan Lerner, Director of Brain Health & Memory Center, UH Cleveland Medical Center, was on the show today and shared more information regarding this clinical study.
Below are the questions Alexa and Hollie asked Alan:
How many people have Alzheimer’s disease?
How many people are expected to have Alzheimer’s disease in 25 years?What is the T2 Protect AD Study?
How did Case Western Reserve University-University Hospitals Cleveland Medical Center become involved?
What is the study treatment and how does it work?
How does the study treatment improve on current standards of care?
Who can participate in this clinical trial?
What can people expect during the screening process?
What can people expect while in the clinical trial?
How do people enroll in the clinical trial?
Where can people get more information?
Will you or someone you know participate in the T2 Protect AD study at Case Western Reserve University-UH Cleveland Medical Center? Tweet us @LIVEONLakeside or find us on Facebook/Instagram at LIVE on Lakeside and let us know!
For More Information:
CALL: 216-464-6467
OR VISIT: T2Protect.org
EMAIL: neuroresearch@UHhospitals.org